# 1. Financial Performance ## A. Key Figures * Consolidated Revenue: **₹567.9 Cr** Q2 FY'26 (+24.1%) * EBITDA: ₹99.5 Cr Q2 FY'26 (+15.8%) · 17.5% EBITDA margin (vs 16.5–17.5% guided) * **PAT:** **₹60.9 Cr** Q2 FY'26 (+13.4%) * **H1 Capex:** **₹150 Cr** (incl. advances) · **Guidance: ₹210–225 Cr** full year ## B. Revenue Growth * **Resilient Top-Line Performance:** Revenue growth maintained despite GST 0 transition disruptions, with strong double-digit underlying demand in core categories. * **Volume-Driven Expansion:** Sales growth primarily fueled by volume gains in office supplies, stationery, adhesives, and kits, with minimal contribution from **2%–3% ASP increases**. * **Domestic Strength, International Growth:** Robust **28% domestic sales growth** offset softer international trends, while overseas markets delivered low-single-digit expansion. * **Acquisition Impact:** First-half growth of 25% significantly influenced by Uniclan consolidation, distorting YoY comparability. ## C. EBITDA Margin * **Margins Held Steady Amid Cost Pressures:** EBITDA margin maintained at 5% despite sharp rise in employee costs, reflecting operational discipline and efficiency gains. * **Elevated Employee Costs Weigh on Leverage:** Employee expenses surged due to sales and production team expansion, including **sales force growth from ~800 to >900**, offsetting scale benefits. * **Preemptive Hiring & Plant Ramp-Up:** Cost loading ahead of new plant startup affected operating leverage, though exact impact remains unquantified by management. * **Margin Philosophy Intact:** Product-level target margins of **15%–16%** continue to drive pricing, with efficiencies translating into reported 5% group EBITDA margin; to be extended to 45-acre expansion. ## D. Profit After Tax * **Bottom-Line Growth Lags Revenue:** PAT rose 4%, reflecting solid earnings conversion despite margin headwinds and higher cost base. ## E. Cash Flow & Capex * **Aggressive Expansion on Track:** Capex execution remains robust, with ₹150 Cr deployed in H1, aligning with full-year guidance and signaling strong commitment to capacity buildout. --- # 2. Volume & Pricing Trends ## A. Key Figures * Discount Incentives & Rebates: ₹37 Cr prior FY · ₹71 Cr FY'25 * **ASP Trend:** **+3% to 4%** company-level primary sales price increase * **MRP Change:** Pencil pack MRP reduced from ₹60 to ₹58 ## B. Sales Volume Growth * **Seasonal Drag:** Q3 volume growth visibility limited by typical Diwali slowdown and a 4–5 day plant shutdown. ## C. Average Selling Price * **Net Price Growth Achieved:** Company-level primary pricing rose modestly despite selective MRP reductions on pencil packs. ## D. Discount & Rebate Impact * **Rebate Expansion:** Discount incentives and rebates as a percentage of sales increased from **5% to 7% YoY**, driven by structural pricing schemes rather than promotional intensity. * **Scheme Mechanics:** Rebates largely reflect **cross-product bundling** (e.g., product B discounted with purchase of product A) embedded in price list structures. * **EBITDA Neutral:** Increased rebates did not pressure margins, as they are factored into standard costing and not incremental to pricing strategy. ## E. MRP Adjustments * **Consumer-Focused Pricing:** MRP reductions on individual items reflect deliberate pass-through of benefits, with clear segmentation maintained between standalone products and combo kits. * **Product Differentiation:** Stand-alone pencil packs continue to be sold at **0% MRP**, underscoring non-interchangeability with bundled offerings. --- # 3. Product & Segment Performance ## A. Key Figures * Scholastic Segment Growth: 4% YoY Q2 (+5.5% H1) * **Office Supplies Growth:** **80%** YoY (unsustainable pace) * ₹593.7 Cr gross product sales included in channel mix, including hygiene segment ## B. Scholastic Stationery * **Brand-Led Growth Strategy:** Marketing focused on targeted, child-centric campaigns including KBC sponsorship and cinema tie-ups with **Superman-themed co-branded launches** driving brand visibility. * **Capacity-Constrained Performance:** Scholastic segment growth remains muted despite positive mix and **slight ASP gains**, limited entirely by lack of capacity expansion. * **New Product Momentum:** Mechanical pencils launched successfully with **positive initial response**, now in production ramp-up phase to support future demand. ## C. Office Supplies * **Capacity-Driven Surge:** Office supplies delivered strong growth following recent capacity additions, with outlook for **healthy expansion** as long as capacity scales. * **Product Cost Structure:** Pens represent the largest input cost in office supplies, followed by markers and highlighters, though exact weights are undisclosed. ## D. Baby Hygiene * **Early-Stage Validation:** Uniclan Healthcare’s baby hygiene line achieved **positive results**, confirming market acceptance and potential for scalable contribution. --- # 4. Capacity & Production ## A. Key Figures * **Capex Efficiency Target:** **INR3** revenue per **INR1** capex * Pen Capacity Expansion: 1 million ballpoint pens/day added; total capacity now 3–3.25 million pens/day, scaling to 5 million pens/day by year-end ## B. Brownfield Expansions * **In-House Nib Manufacturing Initiated:** Upcoming 44-acre plant will enable mass production of pen nibs via imported automated lines, marking a strategic shift despite current reliance on reliable third-party suppliers. * **Capex Discipline Maintained:** Expansion triggered only at **50–60% utilization** with strong demand, targeting high capital efficiency and value-add realization. * **Minimal Margin Impact Expected:** Despite suboptimal initial utilization, management does not foresee significant margin pressure from brownfield ramp-ups. ## C. 45-Acre Project * **Next-Phase Scaling:** The 45-acre project represents the next major capacity leap, focused on high-margin core categories—pencils and pens—without diversification into new product lines. * **Timeline Adjusted:** Slight delay due to monsoon; first building expected in **Q4 FY26**, with commercial production commencing in **Q1 FY27**. ## D. Pen & Pencil Capacity * **Phased Output Growth:** Recent capacity additions are incremental, not lumpy, supporting steady scalability in pen production amid flexible polymer-based manufacturing infrastructure. * **Revenue Contribution Timing:** New pencil capacity to come online from **Q1 FY27**, with meaningful revenue contribution expected by **Q2 FY27**. --- # 5. Channel & Distribution ## A. Key Figures * **General Trade Contribution:** **71%** current quarter (↓ from 77% in Q2 FY'25) * **E-commerce Penetration:** **~35%** of baby hygiene sales * **Regional Growth:** **>60%** in South India · **<10%** in East India ## B. General Trade * **Brand Equity Building:** Aspirational value strengthened via high-reach consumer connect initiatives, including a strategic partnership with *Kaun Banega Crorepati*. * **Channel Mix Shift:** Decline in GT’s share driven by strong performance in baby hygiene, reflecting product-led diversification rather than channel weakness. * **Regional Dynamics:** South India shows robust growth momentum, while East India’s slowdown is temporary, linked to **Durga Puja-related economic pause**. ## C. E-commerce * **Modern Trade Acceleration:** E-commerce now a key driver in baby hygiene, contributing to overall shift away from GT, amplified by GST 0 transition and festive demand. ## D. Quick Commerce * **Tactical Channel Presence:** DOMS supplies directly to dark stores of Blinkit and Instamart for consumer convenience, but quick commerce remains **non-core** to strategy. * **Capacity Reallocation:** U.S. order delays led to reallocation of production to high-growth markets like **Chile**, where FILA distribution is generating **strong repeat orders**. --- # 6. Regulatory & Tax Risks ## A. Key Figures * **GST-Impacted Sales:** **45%** of FY25 sales from 0% GST categories · **6%** from baby hygiene (GST reduced to 5%) * **Kit Taxation Rate:** **18%** applied to most mixed supply kits despite inclusion of 0% GST items ## B. GST 0 Transition * **Structural Benefit with Short-Term Disruption:** GST 0% reforms are structurally positive, enhancing competitiveness of branded goods, but triggered temporary demand pull-forward and order deferrals in September. * **Channel Dynamics Shifted:** GST-related MRP reductions led to credit notes and scheme rebates; festive season inventory clearance accelerated into Q3, pulling forward sales. * **Margin Resilience:** Despite ineligibility of input tax credit on 0% GST goods, MRP adjustments neutralized cost impacts, preserving margin integrity. ## C. Mixed Supply Rules * **Tax Treatment Constrains Pricing Flexibility:** Most product kits classified as mixed supply, subjecting entire bundles to the highest GST rate (18%), limiting tax efficiency opportunities. * **Operational Complexity Rising:** Managing multi-rate GST compliance and ITC eligibility for nil-rated items within taxable kits adds administrative burden. ## D. Tariff Impacts --- # 7. Guidance & Outlook ## A. Key Figures * **Revenue Growth Guidance:** **18%–20%** full-year outlook maintained * EBITDA Margin Guidance: 16.5% to 17.5% target range, unchanged despite expansion ## B. Full-Year Revenue * **Cautious Trajectory:** Management maintains guidance despite strong H1, signaling **gradual H2 acceleration** without a sharp rebound. * **Seasonal Build:** Q3 growth to be muted; restocking expected to unfold steadily into the **December back-to-school season**. ## C. Margin Target * **Stable Margin Outlook:** EBITDA margin guidance held at 5%, reflecting confidence in cost control amid capacity ramp-up. ## D. H2 Growth Drivers * **Macro Tailwinds:** **2025 budget reforms**, including income tax cuts and GST benefits, expected to lift consumer sentiment and disposable income. * **Strategic Leverage:** Growth to be driven by **product launches, market penetration**, and commercialization of the **44-acre expansion project**. * **Capacity-Led Inflection:** Scholastic categories to see incremental gains now, with **major volume ramp-up expected from Q2 FY27**.